Антибиотики и Химиотерапия (May 2020)

Investigation of Molecular Mechanisms of Aminoglycoside Resistance in Salmonella

  • A. V. Zubritskiy,
  • E. N. Ilina,
  • S. A. Strelchenko,
  • M. V. Malakhova,
  • S. V. Lenev,
  • O. D. Sklyarov,
  • A. N. Panin,
  • V. M. Govorun

Journal volume & issue
Vol. 56, no. 9-10
pp. 7 – 12

Abstract

Read online

The spread of aminoglycoside resistance phenotype and respective genetic resistance determinants was evaluated in 243 Salmonella strains isolated within 1948-2010 and stored in the Culture Collection of the Russian State Research Institute for Control, Standardization and Certification of Veterinary Preparations (Moscow). The Salmonella strains showed resistance to streptomycin and gentamicin in 3.7% (n=9) and 0.8% (n=2) of the isolates respectively. Intermediate resistance to streptomycin was recorded in 9.9% (n=24) of the isolates. To detect the genes responsible for the aminoglycoside resistance, primers for aadAl, aadA2, aadB, aphAl, aphA3, sat, strA, strB, aphA, aacC, rmtB, armA and rpsL genes amplification and sequencing were designed. The strains with lower susceptibility to streptomycin harbored aadAl, aadA2, strA, strB resistance genes encoding enzymes for aminoglicoside modification and rpsL mutant allele (K42N, G91D). Genetic mechanisms able to explain the gentamicin resistance development were not detected. Some strains carried genetic markers of streptomycine resistance but had no clinically sufficient resistance to it. In this regard, genetic testing is essential for prevention of drug resistance spreading due to horizontal transfer of genes in microbial population.

Keywords